Schmitt B, Vicenzi M, Garrel C, and Denis FM
Post-hoc analysis of randomised, placebo-controlled, double-blind study (MCI186-19) of edaravone (MCI-186) in amyotrophic lateral sclerosis
Safety and tolerability: Extensive safety research on both individual peptides and the combination shows excellent tolerability minimal adverse effects, no major organ toxicity, no hormonal disruption, and no serious adverse events across thousands of research uses
conducted similar analyses: they detected 188 total metabolites in serum collected 1 and 4 days after severe TBI using 1 H-NMR and mass spectrometry and identified metabolite signatures that predicted favorable/unfavorable outcomes at 3 and 12 months after injury [30]
You can give the shot at a 90-degree angle if 2 inches of skin can be grasped between your thumb and first (index) finger
Several go to the Pharmacy Compounding Advisory Committee for review, with meetings expected through the end of February 2027